We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protein-Folding Computer Game Could Benefit World Health

By Biotechdaily staff writers
Posted on 19 May 2008
A new computer game turns protein folding, a key investigational process for solving biological mysteries ranging from Alzheimer's disease to vaccines, into a competitive sport that may even help find a cure for HIV. More...


The new game, named Foldit, was developed by researchers at the University of Washington (UW, Seattle, USA). The game, at an introductory level, teaches the rules; after about 20 minutes of training, participants feel as if they are playing a video game, but actually are clicking their mouse in the service of science.

Proteins form every cell, make up the immune system, and set the speed of chemical reactions in the human body; however, of the over 100,000 different proteins that exist, there are only a few in which their complex geometrical shapes are known. In many more, the surface anatomy that plays a crucial role in their biologic function remains a mystery. Computer simulators can calculate all possible protein shapes, but this is a computationally complex mathematical problem so intractable that it would take computers centuries to solve.

In 2005, a project named Rosetta@home that taps into volunteers' computer time around the world was developed to help solve the structure of smaller proteins, but as the protein gets larger it becomes much more difficult to solve, and computers often fail at it. Both Rosetta@home and Foldit use the Rosetta protein-folding software. However, Foldit is the first protein-folding project that asks volunteers for something other than unused processor cycles on their computers or Playstation machines. Foldit also differs from recent human-computer interactive games that use humans' ability to recognize images or interpret text; instead, Foldit capitalizes on people's natural three-dimensional (3D) problem-solving skills. Eventually, the researchers hope to discover protein-folding prodigies who have innate abilities to see proteins in 3D.

The game itself looks like an advanced version of Tetris, with multicolored geometric snakes filling the screen. A team that includes six UW graduate and undergraduate students spent more than a year discovering how to make the game both accurate and engaging. Almost 1000 players have tested the system, playing informal challenges using proteins with known shapes. The developers have opened the game to the public, offering proteins of unknown shapes for solution; Foldit gamers will eventually face-off against research groups around the world in a major protein-structure competition to be held every two years. Eventually, the researchers hope to present a medical nemesis, such as HIV or malaria, and challenge players to devise a protein with just the right shape to lock into the virus and deactivate it. Winning protein designs will be synthesized and tested in petri dishes. High-scoring players will be credited in scientific publications the way that top Rosetta@home contributors already are credited for their computer time.

"Long-term, I'm hoping that we can get a significant fraction of the world's population engaged in solving critical problems in world health, and doing it collaboratively and successfully through the game,” said team member Professor David Baker, Ph.D., a UW professor of biochemistry and developer of the Rosetta@home project. "We're trying to use the brain power of people all around the world to advance biomedical research.”


Related Links:
Foldit
Rosetta@home
University of Washington

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.